EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection

Frederik Emil Juul iD, Michael Bretthauer iD, Peter H Johnsen iD, Faye Samy iD, Kristian Tonby, Jan Erik Berdal, Dag Arne L Hoff iD, Eirik H Ofstad iD, Awet Abraham, Birgitte Seip, Håvard Wiig, Øyvind Bakken Rognstad iD und 17 weitere

Annals of Internal Medicine · 2025

DOI: 10.7326/annals-24-03285 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift Annals of Internal Medicine, 2025. Verfasst von Frederik Emil Juul und 28 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway; Clinical Effectiveness Research Group, University of Oslo, Oslo, Norwa…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Clostridium Infections, Fecal Microbiota Transplantation, Vancomycin. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fecal microbiota transplantation (FMT) is recommended for recurrent Clostridioides difficile infection (CDI), but its role in primary CDI is unclear. OBJECTIVE: To investigate the efficacy and safety of FMT in primary CDI. DESIGN: Randomized, open-label, noninferiority, multicenter trial. (ClinicalTrials.gov: NCT03796650). SETTING: Hospitals and primary care facilities in Norway. PATIENTS: Adults with CDI (C difficile toxin in stool and ≥3 loose stools daily) and no previous CDI within 365 days before enrollment. INTERVENTION: FMT without antibiotic pretreatment versus oral vancomycin, 125 mg 4 times daily for 10 days. MEASUREMENTS: The primary end point was clinical cure (firm stools or

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsClostridium InfectionsFecal Microbiota TransplantationVancomycinAdultAgedFemaleHumansMaleMiddle AgedClostridioides difficileRecurrenceTreatment Outcome

Substanzen

Anti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway; Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway; and Vestre Viken Bærum Hospital, Gjettum, Norway (F.E.J.).
  • Clinical Effectiveness Research Group, Oslo University Hospital, and Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway (M.B., M.K., M.L., K.K.G.).
  • Department of Internal Medicine, University Hospital of Northern Norway, Harstad, Norway, and Gastroenterology and Nutrition Research Group, UiT The Arctic University of Norway, Tromsø, Norway (P.H.J., L.K.S.).
  • Frontier Science (Scotland) Ltd, Kingussie, United Kingdom (F.S.).
  • Department of Infectious Diseases, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway (K.T.).
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway, and Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway (J.E.B.).

ORCID-Profile: Frederik Emil Juul, Michael Bretthauer, Peter H Johnsen, Faye Samy, Dag Arne L Hoff, Eirik H Ofstad, Øyvind Bakken Rognstad, Jørgen Valeur, Eivind Ness-Jensen, Linn K Skjevling, Kurt Hanevik, Hilde Skudal, Raziye Boyar, Trond E Ranheim, Mette Kalager, Magnus Løberg, Kjetil K Garborg

Zitieren

APA

Juul, F. E., Bretthauer, M., Johnsen, P. H., Samy, F., Tonby, K., Berdal, J. E., Hoff, D. A. L., Ofstad, E. H., Abraham, A., Seip, B., Wiig, H., Rognstad, Ø. B., Glad, I. F., Valeur, J., Nissen-Lie, A. E., Ness-Jensen, E., Lund, K. M. A., Skjevling, L. K., Hanevik, K., …, & Garborg, K. K. (2025). Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection. Annals of Internal Medicine. https://doi.org/10.7326/annals-24-03285

Vancouver

Juul FE, Bretthauer M, Johnsen PH, Samy F, Tonby K, Berdal JE, et al. Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection. Annals of Internal Medicine. 2025. doi:10.7326/annals-24-03285

BibTeX
@article{Juul2025,
  author = {Juul, Frederik Emil and Bretthauer, Michael and Johnsen, Peter H and Samy, Faye and Tonby, Kristian and Berdal, Jan Erik and Hoff, Dag Arne L and Ofstad, Eirik H and Abraham, Awet and Seip, Birgitte and Wiig, Håvard and Rognstad, Øyvind Bakken and Glad, Ida F and Valeur, Jørgen and Nissen-Lie, Axel E and Ness-Jensen, Eivind and Lund, Kristine M A and Skjevling, Linn K and Hanevik, Kurt and Skudal, Hilde and Melsom, Ellen J and Boyar, Raziye and Cooper, Trond J and Ranheim, Trond E and Riise, Esben M and Adami, Hans-Olov and Kalager, Mette and Løberg, Magnus and Garborg, Kjetil K},
  title = {Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection},
  journal = {Annals of Internal Medicine},
  year = {2025},
  doi = {10.7326/annals-24-03285}
}
Kostenlos starten →